Skip to content
News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Myelodysplastic Syndrome
June 6, 2018
Updates in the Management of Myelodysplastic Syndromes
Dr. C H Weaver MD
June 2, 2018
Vidaza® Improves Survival in Myelodysplastic Syndromes
Dr. C H Weaver MD
June 1, 2018
Revlimid® Effective for Patients with Myelodysplastic Syndromes with Deletion
Dr. C H Weaver MD
June 1, 2018
AMG 531 May Be Effective in Treating Thrombocytopenia in Patients with MDS
Dr. C H Weaver MD
October 31, 2017
Erythropoietin Plus Granulocyte Macrophage Factor for Myelodysplastic Syndrome
Dr. C H Weaver MD
December 20, 2016
Anti-Inflammatory Drug Combination Appears to Improve Blood Counts for Persons
Dr. C H Weaver MD
January 13, 2015
Aggressive Chemotherapy Increases Remission in Patients with High-Risk MDS
Dr. C H Weaver MD
March 11, 2009
Autologous Stem Cell Transplants Prove Promising in Myelodysplastic Syndromes
Dr. C H Weaver MD
March 8, 2009
Further Evidence that Vidaza® Reduces Need for Transfusions in MDS
Dr. C H Weaver MD
March 8, 2009
Revlimid® Approved for Myelodysplastic Syndromes
Dr. C H Weaver MD
March 8, 2009
Thalidomide Effective for Myelodysplastic Syndrome
Dr. C H Weaver MD
March 8, 2009
Revlimid™ Effective for Low-Risk Myelodysplastic Syndromes
Dr. C H Weaver MD
Previous Page
1
2
3
4
Next Page
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
